Please enable JavaScript to continue using this application.

Compare $ICCC vs $OKUR | Chartloom

Compare

$ICCC vs $OKUR

ImmuCell Corp · Onkure Therapeutics Inc

ICCC

ImmuCell Corp

OKUR

Onkure Therapeutics Inc

Compare $ICCC vs $OKUR

Comparing ImmuCell Corp and Onkure Therapeutics Inc

ICCCImmuCell Corp

OKUROnkure Therapeutics Inc

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

OKUROnkure Therapeutics Inc

Market cap

$97M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

71.59x

Rev growth (TTM)

—

YTD performance

-18.6%

52W performance

-20.7%

FCF yield

-49.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ICCC

OKUR

Detailed metrics comparison

ICCC

ImmuCell Corp

OKUR

Onkure Therapeutics Inc

Market Cap

ICCC$89M

OKUR$97M

Enterprise Value

ICCC$88M

OKUR$-69M

Price

ICCC$9.80

OKUR$2.41

P/E Ratio

ICCC114.37x

OKURN/A

P/S Ratio

ICCC2.89x

OKUR0.00x

EV/Sales

ICCC2.87x

OKUR0.00x

EV/EBITDA

ICCC14.10x

OKUR0.00x

P/B Ratio

ICCC2.82x

OKUR0.60x

P/FCF Ratio

ICCC21.04x

OKURN/A

EV/FCF

ICCC20.91x

OKUR1.44x

PEG Ratio

ICCCN/A

OKURN/A

Forward P/E (NTM)

ICCCN/A

OKURN/A

Forward P/S (NTM)

ICCCN/A

OKUR71.59x

Revenue (TTM)

ICCC$31M

OKUR$0

Revenue Growth (YoY)

ICCC8.5%

OKURN/A

Forward Rev Growth

ICCC0.0%

OKUR100.0%

Gross Margin (TTM)

ICCC40.3%

OKUR0.0%

Operating Margin (TTM)

ICCC3.9%

OKUR0.0%

EBITDA Margin (TTM)

ICCC20.4%

OKUR0.0%

Net Margin (TTM)

ICCC2.6%

OKUR0.0%

FCF Margin (TTM)

ICCC13.7%

OKURN/A

Net Income (TTM)

ICCC$787K

OKUR$-59M

FCF (TTM)

ICCC$4M

OKUR$-48M

EPS (TTM)

ICCC$0.09

OKUR-$1.18

ROE (TTM)

ICCC2.7%

OKUR-4902.0%

ROA (TTM)

ICCC1.8%

OKUR-4577.0%

ROIC (TTM)

ICCC2.1%

OKUR-4902.0%

Cash

ICCC$9M

OKUR$167M

Debt

ICCC$8M

OKUR$0

Net Cash/Debt

ICCC$557K

OKUR$167M

Current Ratio (TTM)

ICCC4.75x

OKUR26.75x

Quick Ratio (TTM)

ICCC2.65x

OKUR26.55x

Debt/Equity (TTM)

ICCC0.26x

OKUR0.00x

Debt/Assets (TTM)

ICCC0.0%

OKUR0.0%

Interest Coverage (TTM)

ICCCN/A

OKURN/A

Net Debt/EBITDA (TTM)

ICCC0.00x

OKUR0.00x

Beta

ICCC0.60

OKUR0.19

52W Performance

ICCC48.7%

OKUR-20.7%

YTD Performance

ICCC65.5%

OKUR-18.6%

% from 52W High

ICCC-19.0%

OKUR-55.2%

% from 52W Low

ICCC116.8%

OKUR13.1%

Asset Turnover (TTM)

ICCC0.69x

OKUR0.00x

FCF Yield (TTM)

ICCC4.8%

OKUR-49.2%

Earnings Yield (TTM)

ICCC0.9%

OKUR-60.3%

Dividend Yield (TTM)

ICCCN/A

OKURN/A

Rule of 40

ICCC22.2

OKUR0.0

EV/GP/RG

ICCCN/A

OKURN/A

Ticker research

View ICCC research View OKUR research

Metric	ICCC ImmuCell Corp	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$89M	$97M
Enterprise Value	$88M	$-69M
Price	$9.80	$2.41
P/E Ratio	114.37x	N/A
P/S Ratio	2.89x	0.00x
EV/Sales	2.87x	0.00x
EV/EBITDA	14.10x	0.00x
P/B Ratio	2.82x	0.60x
P/FCF Ratio	21.04x	N/A
EV/FCF	20.91x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$31M	$0
Revenue Growth (YoY)	8.5%	N/A
Forward Rev Growth	0.0%	100.0%
Profitability
Gross Margin (TTM)	40.3%	0.0%
Operating Margin (TTM)	3.9%	0.0%
EBITDA Margin (TTM)	20.4%	0.0%
Net Margin (TTM)	2.6%	0.0%
FCF Margin (TTM)	13.7%	N/A
Net Income (TTM)	$787K	$-59M
FCF (TTM)	$4M	$-48M
EPS (TTM)	$0.09	-$1.18
ROE (TTM)	2.7%	-4902.0%
ROA (TTM)	1.8%	-4577.0%
ROIC (TTM)	2.1%	-4902.0%
Financial Health
Cash	$9M	$167M
Debt	$8M	$0
Net Cash/Debt	$557K	$167M
Current Ratio (TTM)	4.75x	26.75x
Quick Ratio (TTM)	2.65x	26.55x
Debt/Equity (TTM)	0.26x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	0.19
52W Performance	48.7%	-20.7%
YTD Performance	65.5%	-18.6%
% from 52W High	-19.0%	-55.2%
% from 52W Low	116.8%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.00x
FCF Yield (TTM)	4.8%	-49.2%
Earnings Yield (TTM)	0.9%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	22.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ICCC research	View OKUR research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

OKUR

0.00x

ICCC

2.89x

EV/FCF

OKUR

1.44x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

Forward Revenue Growth

OKUR

100.0%

ICCC

0.0%

Profitability & performance

Gross Margin

ICCC

40.3%

OKUR

0.0%

ROE

ICCC

2.7%

OKUR

-4902.0%

FCF Yield %

ICCC

4.8%

OKUR

-49.2%

52-Week Performance

ICCC

48.7%

OKUR

-20.7%

Detailed metrics comparison

ICCC

ImmuCell Corp

OKUR

Onkure Therapeutics Inc

Market Cap

ICCC$89M

OKUR$97M

Enterprise Value

ICCC$88M

OKUR$-69M

Price

ICCC$9.80

OKUR$2.41

P/E Ratio

ICCC114.37x

OKURN/A

P/S Ratio

ICCC2.89x

OKUR0.00x

EV/Sales

ICCC2.87x

OKUR0.00x

EV/EBITDA

ICCC14.10x

OKUR0.00x

P/B Ratio

ICCC2.82x

OKUR0.60x

P/FCF Ratio

ICCC21.04x

OKURN/A

EV/FCF

ICCC20.91x

OKUR1.44x

PEG Ratio

ICCCN/A

OKURN/A

Forward P/E (NTM)

ICCCN/A

OKURN/A

Forward P/S (NTM)

ICCCN/A

OKUR71.59x

Revenue (TTM)

ICCC$31M

OKUR$0

Revenue Growth (YoY)

ICCC8.5%

OKURN/A

Forward Rev Growth

ICCC0.0%

OKUR100.0%

Gross Margin (TTM)

ICCC40.3%

OKUR0.0%

Operating Margin (TTM)

ICCC3.9%

OKUR0.0%

EBITDA Margin (TTM)

ICCC20.4%

OKUR0.0%

Net Margin (TTM)

ICCC2.6%

OKUR0.0%

FCF Margin (TTM)

ICCC13.7%

OKURN/A

Net Income (TTM)

ICCC$787K

OKUR$-59M

FCF (TTM)

ICCC$4M

OKUR$-48M

EPS (TTM)

ICCC$0.09

OKUR-$1.18

ROE (TTM)

ICCC2.7%

OKUR-4902.0%

ROA (TTM)

ICCC1.8%

OKUR-4577.0%

ROIC (TTM)

ICCC2.1%

OKUR-4902.0%

Cash

ICCC$9M

OKUR$167M

Debt

ICCC$8M

OKUR$0

Net Cash/Debt

ICCC$557K

OKUR$167M

Current Ratio (TTM)

ICCC4.75x

OKUR26.75x

Quick Ratio (TTM)

ICCC2.65x

OKUR26.55x

Debt/Equity (TTM)

ICCC0.26x

OKUR0.00x

Debt/Assets (TTM)

ICCC0.0%

OKUR0.0%

Interest Coverage (TTM)

ICCCN/A

OKURN/A

Net Debt/EBITDA (TTM)

ICCC0.00x

OKUR0.00x

Beta

ICCC0.60

OKUR0.19

52W Performance

ICCC48.7%

OKUR-20.7%

YTD Performance

ICCC65.5%

OKUR-18.6%

% from 52W High

ICCC-19.0%

OKUR-55.2%

% from 52W Low

ICCC116.8%

OKUR13.1%

Asset Turnover (TTM)

ICCC0.69x

OKUR0.00x

FCF Yield (TTM)

ICCC4.8%

OKUR-49.2%

Earnings Yield (TTM)

ICCC0.9%

OKUR-60.3%

Dividend Yield (TTM)

ICCCN/A

OKURN/A

Rule of 40

ICCC22.2

OKUR0.0

EV/GP/RG

ICCCN/A

OKURN/A

Ticker research

View ICCC research View OKUR research

Metric	ICCC ImmuCell Corp	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$89M	$97M
Enterprise Value	$88M	$-69M
Price	$9.80	$2.41
P/E Ratio	114.37x	N/A
P/S Ratio	2.89x	0.00x
EV/Sales	2.87x	0.00x
EV/EBITDA	14.10x	0.00x
P/B Ratio	2.82x	0.60x
P/FCF Ratio	21.04x	N/A
EV/FCF	20.91x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$31M	$0
Revenue Growth (YoY)	8.5%	N/A
Forward Rev Growth	0.0%	100.0%
Profitability
Gross Margin (TTM)	40.3%	0.0%
Operating Margin (TTM)	3.9%	0.0%
EBITDA Margin (TTM)	20.4%	0.0%
Net Margin (TTM)	2.6%	0.0%
FCF Margin (TTM)	13.7%	N/A
Net Income (TTM)	$787K	$-59M
FCF (TTM)	$4M	$-48M
EPS (TTM)	$0.09	-$1.18
ROE (TTM)	2.7%	-4902.0%
ROA (TTM)	1.8%	-4577.0%
ROIC (TTM)	2.1%	-4902.0%
Financial Health
Cash	$9M	$167M
Debt	$8M	$0
Net Cash/Debt	$557K	$167M
Current Ratio (TTM)	4.75x	26.75x
Quick Ratio (TTM)	2.65x	26.55x
Debt/Equity (TTM)	0.26x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	0.19
52W Performance	48.7%	-20.7%
YTD Performance	65.5%	-18.6%
% from 52W High	-19.0%	-55.2%
% from 52W Low	116.8%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.00x
FCF Yield (TTM)	4.8%	-49.2%
Earnings Yield (TTM)	0.9%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	22.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ICCC research	View OKUR research